Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Response to L-DOPA in multiple system atrophy

E A Parati1, V Fetoni, G C Geminiani

  • 1Istituto Nazionale Neurologico C. Besta, Milan, Italy.

Clinical Neuropharmacology
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating behavioral assessment in instructional design for competency-based medical education.

Frontiers in medicine·2024
Same author

Adult-onset Still's disease: analysis of a monocentric cohort of patients.

Scandinavian journal of rheumatology·2024
Same author

Ossiculoplasty in incudostapedial joint defects: audiologic outcomes of three type of partial ossicular prostheses in retrospective clinical study 1995-2015.

American journal of otolaryngology·2022
Same author

Manufacturing, installation, commissioning, and first results with the 3D low-temperature co-fired ceramic high-frequency magnetic sensors on the Tokamak à Configuration Variable.

The Review of scientific instruments·2020
Same author

Long-term results of nasal surgery: comparison of mini-invasive turbinoplasty.

Journal of biological regulators and homeostatic agents·2020
Same author

Adipose tissue-derived mesenchymal stromal cells for clinical application: An efficient isolation approach.

Current research in translational medicine·2018
Same journal

Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

Clinical neuropharmacology·2026
Same journal

Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

Clinical neuropharmacology·2026
Same journal

Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

Clinical neuropharmacology·2026
Same journal

A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

Clinical neuropharmacology·2026
Same journal

Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

Clinical neuropharmacology·2026
Same journal

Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

Clinical neuropharmacology·2026
See all related articles

Patients with multiple system atrophy (MSA) often show a poor response to Levodopa (L-DOPA), unlike Parkinson's disease (PD) patients. This study found differing motor responses to L-DOPA between MSA and PD, unrelated to drug metabolism.

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Multiple System Atrophy (MSA) is clinically characterized by parkinsonian, cerebellar, and autonomic signs.
  • A poor response to Levodopa (L-DOPA) is often considered a hallmark of MSA.
  • Distinguishing MSA from Parkinson's Disease (PD) is crucial for appropriate patient management.

Purpose of the Study:

  • To compare the motor response to L-DOPA in patients with MSA versus PD.
  • To investigate the peripheral pharmacokinetics of L-DOPA in both patient groups.
  • To explore the relationship between L-DOPA response and disease-specific neurodegeneration.

Main Methods:

  • Eight patients with MSA and eight patients with PD experiencing "on-off" phenomena were enrolled.
  • A single oral dose of 250 mg L-DOPA/25 mg carbidopa was administered.

Related Experiment Videos

  • Motor responses and L-DOPA peripheral pharmacokinetics were evaluated.

    • Main Results:

    • All PD patients exhibited a consistently good motor response to L-DOPA.
    • Only four out of eight MSA patients showed a moderate motor response.
    • No significant differences in L-DOPA pharmacokinetic parameters were observed between the groups.

    Conclusions:

    • The differential motor response to L-DOPA in MSA compared to PD is not explained by peripheral drug metabolism.
    • Variations in the extent of putaminal degeneration likely account for the differing L-DOPA responses in MSA.
    • These findings underscore the importance of considering neurodegenerative patterns in L-DOPA treatment response.